## SHW: The Sherwin-Williams Company - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -1.2% below STRENGTH zone (4.0-10.0%); PEG 3.14 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($325.64)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. CFO Mistysyn Acquires 223 Of Sherwin-Williams Co [SHW]**
- Source: TradingView | 20251203T235324 | Neutral | Relevance: 100%
- Sherwin-Williams Co's CFO, Allen J. Mistysyn, acquired 223 shares of the company's stock through an exercise and surrender transaction on December 1, 2025. This transaction involved the exercise of 802 shares and the surrender of 579 shares, resulting in ending holdings of 73,923 shares. The Washington Service provides further details on insider trading analysis.

**2. Sherwin-Williams (SHW) CFO exercises options, reports updated direct and indirect holdings**
- Source: Stock Titan | 20251203T182000 | Neutral | Relevance: 100%
- Sherwin-Williams' (SHW) SVP of Finance & CFO, Allen J. Mistysyn, exercised employee stock options for 338 shares at $295.83 and 464 shares at $215.08 on December 1, 2025. The filing also detailed dispositions of shares to cover taxes and updated direct ownership to 13,273â€“13,562 shares, including restricted stock units, along with indirect holdings through a 401(k) plan, a trust, and a spouse. After these transactions, the CFO retains 15,662 and 14,336 remaining stock options from grants made in October 2021 and October 2022, respectively.

**3. Sherwin-Williams Co. stock underperforms Tuesday when compared to competitors**
- Source: MarketWatch | 20251202T214200 | Somewhat-Bearish | Relevance: 100%
- Sherwin-Williams Co. stock (SHW) closed down 1.17% on Tuesday, underperforming the broader stock market, which saw the S&P 500 and Dow Jones Industrial Average both rise. This marks the second consecutive day of losses for the company's shares. The stock's performance contrasts with the overall favorable trading session.

**4. Sherwin-Williams Stock Prediction: Where Analysts See the Stock Going by 2027**
- Source: TIKR.com | 20251201T205144 | Somewhat-Bullish | Relevance: 100%
- This article analyzes analyst predictions for Sherwin-Williams (NYSE: SHW) stock by 2027, factoring in current trading prices, analyst price targets, and growth outlooks. It highlights modest upside potential based on average estimates, driven by the company's strong franchise, strategic investments, and expected gradual market recovery. The analysis also considers bear case factors such as premium valuation and cyclical headwinds.

**5. Mizuho Lifts Sherwin-Williams (SHW) Price Target to $400 After Solid Q3 Results**
- Source: MSN | 20251201T170629 | Bullish | Relevance: 100%
- Mizuho increased its price target for Sherwin-Williams (SHW) to $400 from $375, maintaining a "Buy" rating, following the company's strong third-quarter results. The upgrade reflects improved sales trends, resilient margins, and positive momentum from the consumer brands group, which countered weakness in architectural new residential coatings. Though the analysts anticipate a challenging fourth quarter due to unfavorable weather and ongoing B2B trends, they foresee strong growth in 2024 driven by higher volumes and an easier comparison.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 16 ($0.21M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+1.4%)
- Blackrock Inc.: 7.1% (-0.7%)
- State Street Corpora: 6.2% (-0.9%)
- Price (T.Rowe) Assoc: 3.6% (-1.7%)
- Morgan Stanley: 2.9% (+1.8%)

### Key Risks

1. Valuation stretched: PEG 3.1x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.14 signals overvaluation risk, limited margin of safety. Forward P/E 27.0x stretched relative to 11% growth. Quality metrics strong (ROE 60%). Balance sheet: $1.1B free cash flow. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $81.1B |
| Beta | 1.24 |
| 52W Range | $308.84 - $379.65 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.14 |
| Forward P/E | 27.0 |
| Current P/E | 29.8 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.0% to -1.2% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.2pp (needs >4.0% for momentum thesis). Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (0.75), confirming momentum. RSI neutral at 51. OFD pattern: +DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.19% (CS: 40) | Neutral |
| RSI_14 | 50.7 | Neutral |
| MACD Histogram | 0.75 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.003x | Above |
| vs SMA200 | 0.978x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $339.24
- **Stop Loss:** $325.64 (4.0% risk)
- **Target:** $352.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 69
- **Position Value:** $23,407.56
- **Portfolio %:** 23.41%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-03 (Est: $2.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.44 | $3.59 | +4.4% |
| 2025Q2 | $3.81 | $3.38 | -11.2% |
| 2025Q1 | $2.16 | $2.25 | +4.1% |
| 2024Q4 | $2.06 | $2.09 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*